What Analysts Are Saying About Humana Stock
Portfolio Pulse from Benzinga Insights
In the past three months, 11 analysts have provided ratings for Humana (NYSE:HUM), with a mix of bullish, somewhat bullish, and indifferent perspectives. The average 12-month price target is $369.64, a slight decrease from the previous $377.88. Key analysts have adjusted their ratings and price targets, reflecting varied sentiments about Humana's market performance.
July 15, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed views on Humana, with recent ratings showing a range of perspectives from bullish to indifferent. The average 12-month price target has decreased slightly to $369.64. Key analysts have adjusted their ratings and price targets, reflecting varied sentiments about Humana's market performance.
The mixed analyst ratings and slight decrease in the average price target suggest a neutral short-term impact on Humana's stock price. While some analysts have raised their price targets, others have lowered them, indicating varied sentiments about the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100